Insight. Invest. Inspire. | Indian markets. No noise. Just the signal
Joined March 2025
- Tweets 5,347
- Following 53
- Followers 49
- Likes 32
7 Photos and videos
Nikhil Kamath invests ‹50Cr in Foodstories. What nobody's saying: This is a bet that India’s wealth gap is permanent. Smart money is exiting the 'value' struggle to capture the high-margin, recession-proof spending of the urban elite. 📈
3
FPI selling is slowing and Prashant Jain is pivoting to large-cap banks. What nobody’s saying: the easy money in frothy mid-caps is over. Smart money is rotating back to the boring giants because that's where the actual valuation safety net remains 🏦
5
Aurobindo Pharma’s Eugia Unit III gets USFDA's OAI status. Management says no immediate impact, but that's a distraction. The real blow is the complete halt on new product approvals from this site, effectively killing its growth pipeline for the near term.
5
Iran peace deal isn't just about lower oil; it's a massive relief valve for L&T, KEC, and KRBL. While markets cheer the news, the real story is the clearing of execution bottlenecks for L&T’s ₹7.4L cr order book. The risk premium is finally melting away.
24
Vedanta Aluminium lists Monday. Projected at ₹420-450, it means early investors effectively get the Oil & Gas and Power arms for free. With costs down 37% in 14 quarters, this is no longer a commodity play—it's a massive manufacturing margin arbitrage. 🚀
121
Vedanta demerger units debut Monday. The market isn't just pricing growth; it’s pricing debt distribution. Aurobindo Pharma’s OAI status is the real red flag—this isn't just a compliance note, it's a potential precursor to a US FDA ban. Handle with care.
103
Asian Paints flags a "dynamic" FY27. Translation: The Grasim entry is hurting more than they admit. They're adding 6,000 touchpoints to defend their turf, but when a market leader talks this much about "discipline," expect margin compression soon.
39
NSE is scaling Electronic Gold Receipts to make India a 'price maker' in gold. The shift to 10mg trading units is the hook. What nobody is saying: this is a death warrant for the opaque spreads local jewellers charge on physical buybacks. ⚖️
15
Jun 14
Nifty is eyeing 24,000 as range-bound boredom ends. While the US-Iran 'thaw' is the headline trigger, the real signal is the Rupee at 94.9. Markets are pricing in a structural drop in inflation before the data even hits the tape. Momentum is back.
53
Jun 14
SpaceX hits a $2.1T valuation on day one. What nobody’s saying: This IPO effectively kills the ‘traditional valuation’ era. When a company is priced as a bet on the future of the planet, P/E ratios become irrelevant. We are now in a narrative-driven market. 📈
5
Jun 14
Dr Reddy's launches generic Bosulif in the US with exclusive marketing rights. This isn't just another generic launch—it’s a play for a $250M oncology niche. The real signal: DRL is pivoting to complex drugs to escape the price erosion killing base generics.
21
Jun 14
KIMS promoters are injecting 600Cr via warrants. What nobody's saying: By locking in a conversion price at current levels, the promoters are effectively call-optioning their own stock, signaling they expect massive margin expansion from their new hospital...
1
18
Jun 13
SpaceX just minted 4,400 employee millionaires. But here is the catch: these massive IPOs are becoming exit liquidity events for VCs rather than entry points for retail. The era of buying a 'cheap' future giant on day one is officially dead.
1
15
Jun 13
NLC India bags Govindpur critical mineral block. Forget lignite; this is a high-stakes play for Vanadium and Titanium. The implication? NLC is morphing into a strategic tech-metal supply chain player, making its old 'utility' valuation model obsolete. 🚀
49
Jun 13
Bansal Wire's trial order for steel tyre cord is the pivot from commodity to tech-heavy specialty steel. It's an entry into a high-barrier oligopoly. Forget the 70bps margin dip; smart money is watching the validation from a tier-1 tyre major. 📈
5
Jun 13
Ashoka Buildcon bags the Raipur Gems & Jewellery Park project. After a 44% crash from its 52-week high, this pivot to industrial PPP shows the company is hunting for margin-heavy assets to stop the bleeding in its stock price. 📉
38
Jun 13
India Inc’s cash hoard hit $200B in FY26. What nobody’s saying: This liquidity trap means companies are too scared to bet on the Indian consumer. When RIL and L&T prefer low-yield cash over new factories, your growth story has a serious demand problem. 🏦
2
Jun 13
Nifty hits 23,500 on a short-covering spree. What nobody’s saying: The 1,000-point target cut by Citi proves the 'India premium' is under pressure. Smart money is fleeing expensive midcaps for defensive private banks and pharma. The froth is finally settling.
33
Jun 13
Elon Musk is the world's first trillionaire after the SpaceX IPO. What nobody is saying: We’ve moved from 'Too Big to Fail' banks to 'Too Big to Regulate' individuals. His net worth is now a geopolitical lever, not just a balance sheet. 🚀
8
Jun 13
Razorpay’s $5-6B IPO isn't just another fintech listing. The 50% fresh issue shows they’re hunting for growth capital, not just dumping VC bags. If they can price this right, they’ll break the 'expensive Indian fintech' curse that's haunted us since 2021.
2